NCT04219904View on ClinicalTrials.gov

PET/MRI Scan for the Evaluation of Resectable Stage IA1-IB3 Cervical Cancer

EARLY_PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

September 7, 2018

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
Stage IA Cervical CancerStage IA1 Cervical CancerStage IA2 Cervical CancerStage IB Cervical CancerStage IB1 Cervical CancerStage IB2 Cervical CancerStage IB3 Cervical Cancer
Interventions
OTHER

Fludeoxyglucose F-18

Given IV

DRUG

Gadobutrol

Given IV

PROCEDURE

Magnetic Resonance Imaging

Undergo PET/MRI

PROCEDURE

Positron Emission Tomography

Undergo PET/MRI

Trial Locations (1)

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER